Zheng C, Zhou Y, Wang Y, Luo Y, Tu C, & Min L. (2020). The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution. Dove Medical Press.
Chicago Style (17th ed.) CitationZheng C, Zhou Y, Wang Y, Luo Y, Tu C, and Min L. The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution. Dove Medical Press, 2020.
MLA (9th ed.) CitationZheng C, et al. The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.